• BX Home
  • GlaxoSmithKline plc: News [Page 9]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

GLAXOSMITHKLINE PLC

GlaxoSmithKline plc (GSK) is currently the second-largest pharmaceutical company in the world. Its pharmaceutical segment covers anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. The company produces the popular asthma medicine Advair. GSK’s consumer healthcare segment handles products such as oral healthcare, nutritional drinks, and over the counter medicines. Founded in 1935, GSK’s headquarters are located in Uxbridge, UK.

GlaxoSmithKline plc is part of Business Exchange, suggested by Ulli Muenker. This topic contains 758 news and 87 blog items. Read updated news, blogs, and resources about GlaxoSmithKline plc. Find user-submitted articles and reactions on GlaxoSmithKline plc from like-minded professionals.

News

Recent news on this topic.

Healthcare: Left to its own devicesmore

Extract not available.

Glaxosmithkline hit by cuts to medical spendingmore

Glaxosmithkline warned European governments are forcing through painful cuts to medical spending in a drive to tackle...

InterMune Shares Popped: What You Need to Knowmore

working with Goldman Sachs on a potential sale of the company. An analyst quoted by Bloomberg speculated that...

Regeneron grabs drug-sector spotlightmore

and the NYSE Arca Biotechnology Index /quotes/comstock/10t!btk.x BTK +2.46% �� jumped 2.1% to 1,481. GlaxoSmithKline...

PhillyInc: Reaching beyond the moon to harness the sun kanaley edit x5...more

focused on middle-market companies within driving distance from Philadelphia, he said. SR One, the venture capital arm...

GlaxoSmithKline Q1 net profit up 14%more

LONDON - Pharmaceutical company GlaxoSmithKline on Wednesday reported a 14 percent increase in first-quarter net...

Seven bets for a better year for business in 2011more

Extract not available.

Europe's Stocks Extend Streak to Fivemore

and a cautiously confident outlook. STMicroelectronics fell 3.7% in Paris as first-quarter sales fell short of...

Degree of logic needed for corporate successmore

Extract not available.

A bitter pill for future of British sciencemore

Extract not available.

Glaxo, Aggreko shine in flat Londonmore

on Wednesday as disappointing corporate updates from Associated British Foods PLC and Barclays PLC offset well-received...

Ericsson, Nokia propel Europe gainsmore

Following results, BP and GlaxoSmithKline help support London ��� Previous Column First Take ��� Story Quotes Comments...

FMCG firms margins seen strainedmore

in quarterly profit for Colgate Palmolive, an 18 percent rise for Marico and a 22 percent rise for Glaxosmithkline...

Meet the Cash Kings of Pharmaceuticalsmore

Pfizer and Merck have both seen their margins decline from five years ago, partially because of recent megamergers.

Biotech Stocks: Regeneron, Glaxo gain in early actionmore

is developing Zaltrap with French drug maker Sanofi-Aventis (NYSE:SNY) Sanofi shares were up marginally at $39.02.

Regeneron, Glaxo gain in early actionmore

European regulatory approval during the second half of the year. Sanofi shares were up marginally at $39.02.

Andrew Witty of GSK: 'Big firms have allowed themselves to be seen as ...more

The GlaxoSmithKline chief executive is determined that his company remain based in the UK for the long term Stateless?...

Fed announces rate decision, Wednesdaymore

Inc. Catalyst Paper Corp. Cenovus Energy Inc. ConocoPhillips Co. Corning Inc. eBay Inc. Firstservice Corp.

Rare diseases: Will push for treatments pay off?more

Ed Mascioli of Pfizer Inc., the world's largest drug company. Some other companies, including Novartis AG and...

GlaxoSmithKline sales drop, outlook brightensmore

By Sten Stovall LONDON (MarketWatch) �� GlaxoSmithKline PLC Wednesday posted a 10.5% fall in first-quarter revenue,...

Footsie buoyed by firmer prices for technology and energy stocksmore

weeks, as the oil explorer said it will spend as much as $100 million to buy back shares. GlaxoSmithKline and Barclays,...

GSK eyes healthier times beyond Q1 flu sales gapmore

- A sharp fall in sales of flu products after last year's pandemic-linked windfall will weigh on GlaxoSmithKline's (GSK.

Tomorrow���s Tape: Bernanke Speaks���more

Inc Equity Residential Ericsson Ethan Allen Interiors Inc Exelon Corp General Dynamics Corp General Maritime Corp.

REFILES-UK Stocks -- Factors to watch on Tuesday April 26more

following two sessions. Lender Barclays (BARC.L), integrated oil giant BP (BP.L), and drugsmakers AstraZeneca (AZN.

Strong earnings help FTSE hit 9-week closing highmore

the sector on valuation grounds and remained positive on the prospects for the integrated oils share prices.

Top Sources: GlaxoSmithKline plc

  • Financial Times
  • Morningstar.com
  • MarketWatch
  • BusinessWeek
  • TheStreet.com
  • Reuters UK
  • Philadelphia Inquirer
  • Reuters
  • google.com
  • online.wsj.com

Most Active Users in this Topic

see all contributors in GlaxoSmithKline plc

Featured White Papers

Post a Job

Jobs in this Topic

Therapeutic (Respiratory) Sales Specialist - Seattle, Washin GlaxoSmithKline | Seattle, WA
Posted: May 23
Therapeutic Respiratory Sales Professional - Hackensack NJ ( GlaxoSmithKline | Hackensack, NJ
Posted: May 23
HIV Clinical Specialist GlaxoSmithKline | Bronx, NY
Posted: May 23
Medical Dir Safety Evaluation and Risk Management/Director H GlaxoSmithKline | Collegeville, PA
Posted: May 23
GlaxoSmithKline GlaxoSmithKline | Research Triangle Park, NC
Posted: Mar 3

Report comment contains invalid characters. ()
cancel
Search Cancel